CVRx stock falls 6.99 percent as CFO transition takes shape
Published on 09/25/2026 at 11:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CVRx stock stood at USD 2.53 on Nasdaq on September 24, 2026, down 6.99 percent from the prior close. The move comes as John Landry prepares to take over as chief financial officer on October 12, 2026, after the company files its third-quarter Form 10-Q, according to the SEC filing dated September 16, 2026.
Landry sets a near term checkpoint
CVRx announced Landry as successor to Jared Oasheim on September 21, 2026. The filing states that Oasheim will remain during a transition period, tying the leadership change to the next quarterly reporting cycle.
The Nasdaq-listed company develops neuromodulation devices for cardiovascular disease, with Barostim as its principal commercial product. The transition therefore arrives before the next disclosed quarterly filing rather than at a distant annual reporting date.
Revenue grows while losses persist
CVRx generated USD 15.71 million in Q2 2026 revenue, up 16 percent from the prior year and above the USD 15.55 million consensus estimate, according to Investing.com. Diluted EPS was a loss of USD 0.53, missing the USD 0.52 consensus loss by USD 0.01.
The quarterly revenue increase contrasts with the company financial profile. Operating loss reached USD 13.02 million in Q2 2026, compared with USD 12.16 million in Q1 2026, while operating cash flow was negative USD 8.83 million in Q2.
Guidance keeps valuation under pressure
CVRx cut its fiscal-year 2026 revenue guidance to USD 58 million to USD 60 million from USD 63 million to USD 67 million in the August 6 update, according to a Morningstar report. That range implies a lower midpoint than the earlier outlook, adding financial pressure to the CFO transition.
At USD 2.53, CVRx carried a market capitalization of USD 67.14 million on September 24, 2026. Its 52-week range was USD 2.20 to USD 11.30, placing the stock USD 0.33 above its yearly low.
CVRx stock facts
- Company: CVRx, Inc.
- Ticker: CVRX
- Trading venue: Nasdaq Global Select Market
- Price as of September 24, 2026: USD 2.53
- Market capitalization: USD 67.14 million as of September 24, 2026
- 52-week range: USD 2.20-11.30 as of September 24, 2026
- Sector / Industry: Healthcare / Medical Devices
